+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

Spatial Genomics & Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Spatial Genomics & Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • January 2026
  • 150 Pages
  • Global
From
Throughput Single Cell Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Throughput Single Cell Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • December 2025
  • 150 Pages
  • Global
From
RNA Transcriptome Profiling Test Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

RNA Transcriptome Profiling Test Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • September 2025
  • 150 Pages
  • Global
From
Viral Gene Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Viral Gene Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • September 2025
  • 150 Pages
  • Global
From
Single-Cell Whole Transcriptome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Single-Cell Whole Transcriptome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • September 2025
  • 150 Pages
  • Global
From
Unlocking Opportunity: Dominate the Market of Conjugated Drugs (XDCs) in Oncology with Confidence - Product Thumbnail Image

Unlocking Opportunity: Dominate the Market of Conjugated Drugs (XDCs) in Oncology with Confidence

  • Directory
  • June 2026
  • Global
From
PARP Inhibitor Biomarkers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Thumbnail Image

PARP Inhibitor Biomarkers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • May 2026
  • 130 Pages
  • Global
From
Targeted Cancer Therapy Market: Analysis by Disease Indication; Therapy Type; End-User, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035 - Product Thumbnail Image

Targeted Cancer Therapy Market: Analysis by Disease Indication; Therapy Type; End-User, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035

  • Report
  • February 2026
  • 240 Pages
  • Global
From
Biosimulation Market (2025 Edition) - Product Thumbnail Image

Biosimulation Market (2025 Edition)

  • Report
  • December 2025
  • 241 Pages
  • Global
From
U.S. Bispecific Antibodies Market Forecast to 2033 - Product Thumbnail Image

U.S. Bispecific Antibodies Market Forecast to 2033

  • Report
  • October 2025
  • 100 Pages
  • United States
From
Europe Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Europe Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 80 Pages
  • Europe
From
North America Gene Expression Market Report and Forecast 2025-2034 - Product Thumbnail Image

North America Gene Expression Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 250 Pages
  • North America
From
Southeast Asia Oncology Drug Access Market - Strategic Insights and Forecasts (2026-2031) - Product Thumbnail Image

Southeast Asia Oncology Drug Access Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • May 2026
  • 102 Pages
  • Asia Pacific
From
North America Antibody Drug Conjugates Market - Strategic Insights and Forecasts (2026-2031) - Product Thumbnail Image

North America Antibody Drug Conjugates Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • May 2026
  • 95 Pages
  • North America
From
Melanoma Cancer Market in the United States - Product Thumbnail Image

Melanoma Cancer Market in the United States

  • Report
  • May 2026
  • 170 Pages
  • United States
From
Middle East and Africa Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 70 Pages
  • Middle East, Africa
From
Asia-Pacific Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 97 Pages
  • Asia Pacific
From
GCC AI in Genomics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

GCC AI in Genomics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 82 Pages
  • Middle East
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
AI-based Drug Discovery Market: Distribution by Drug Discovery Steps, Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

AI-based Drug Discovery Market: Distribution by Drug Discovery Steps, Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • April 2022
  • 334 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more